March 9, 2026

Background

Brian Rifkin

Is REACT (Renal Autologous Cell Therapy) the ...

This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.

February 23, 2026

Background

Brian Rifkin

2026 KDIGO Anemia Management Guidelines

This week, we will discuss 2026 KDIGO anemia management in patients with kidney disease

February 8, 2026

Background

Cristina Adriana Popa

To INFINITI and Beyond: SGLT2 Inhibitors in ...

This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.

January 26, 2026

Background

Cristina Adriana Popa

POTCAST- K+ Pop and Arrhythmia Drop

This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.

January 11, 2026

Background

Brian Rifkin

A VALIANT effort to combat complement disorders ...

This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.

folic acid

swapnil hiremath

October 6, 2016

storify

The Folate #NephJC wrap up

swapnil hiremath

October 6, 2016

storify

Excellent discussion.Hosted by #NSMC graduate Scherly Leon (making her debut) and the redoubtable Ian Logan respectively.

swapnil hiremath

September 30, 2016

Background

Could it be that Simple: A Vitamin to Protect the Kidney?

swapnil hiremath

September 30, 2016

Background

Could it be that Simple: A Vitamin to Protect the Kidney?

Hyperhomocysteinemia was all the rage a few years ago. Sadly, as is often the case, trials to lwoer homocysteine failed to show much clinical benefit. Now comes a trial to test the effect of follic acid, on CKD prevention. With an N > 15,000 - this should make for an interesting NephJC discussion.